At COO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top New Jersey based COO’ operating in the Biotechnology space. If you think a COO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Howard Dubinett
EVP & COO of Bio-Reference Laboratories
Follow Howard Dubinett:
About Bio-Reference Laboratories: BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing .
Brendan Delaney
Chief Operating Officer of Aadi Bioscience
Follow Brendan Delaney:
About Aadi Bioscience, Constellation Pharmaceuticals: Aadi Bioscience develops a potentially mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases.
Greg Williams
Chief Operating Officer of Eloxx
Gregory Williams has served as our Chief Operating Officer since June 2018. Gregory Williams has over 30 years of pharmaceutical and biotechnology experience leading regulatory affairs, compliance, quality, manufacturing, commercial and product development programs. Gregory Williams is an accomplished scientist and seasoned pharmaceutical executive with a solid track record of successful achievement of business, medical, scientific and regulatory goals. His focus is on driving innovation to improve patient care by developing and commercializing new products to address unmet patient and health system needs. While at The Medicines Company, Gregory Williams led development and successful approval of the antihypertensive drug, Cleviprex®. Gregory Williams also worked on the orphan drug programs at NPS Pharmaceuticals, Inc. Most recently, while at Radius Health, Inc., Gregory Williams led the successful first cycle approval by the FDA of TYMLOS™. Gregory Williams brings established relationships with global health authority reviewers, having led the development and/or initial and expanded approvals of several global brands, as well as expertise across a wide range of therapeutic categories, molecule types, dosage forms and technologies. Gregory Williams holds a Ph.D. in Biopharmaceutics from Rutgers University and an M.B.A. from Cornell University.
Follow Greg Williams:
About Eloxx: Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Keith Westby
Chief Operating Officer of IVERIC bio
Keith Westby is our Vice President of Project Management. Keith has more than 15 years of experience in project and strategic alliance management and manufacturing operations in Biotech companies, two of which executed successful IPOs. Keith was most recently at Pharmasset, Inc., as Director, Project and Alliance Management, accountable for developing and implementing strategy across manufacturing, research and development, preclinical, clinical, regulatory, and finance for both internal and partnered projects. Prior to that Keith served in positions of increasing responsibility at Eyetech Pharmaceuticals, most recently as Director, Alliance & Project Management, leading multifunctional project teams in the NDA filing and marketing approval of Macugen® for Age-Related Macular Degeneration. Previously, Keith was at Tunnell Consulting, where he was a Senior Consultant in the firm’s Life Sciences practice focused on manufacturing operations and process improvement. Keith holds a B.S. in Applied Physics from the State University of New York, College at Geneseo, an M.S. in Engineering Management from Drexel University, and an MBA from Columbia Business School.
Follow Keith Westby:
About IVERIC bio: IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Piyush Sadana
Co-Founder and COO of RICOVR Healthcare Inc.
Piyush Sadana is the Co-Founder and Chief Operating Officer of Ricovr Healthcare.
Follow Piyush Sadana:
About RICOVR Healthcare Inc.: RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
Bradley L Campbe
Chief Operating Officer of Amicus Therapeutics
Bradley L. Campbell joined Amicus in May 2006 and currently serves as Chief Operating Officer. He brings 15 years of experience in the biotech and pharmaceutical industries. Prior to Amicus, Mr. Campbell was with Genzyme Corporation, where he first served as Sr. Product Manager for Myozyme®, an enzyme replacement therapy for Pompe disease. He then became a Business Director in Genzyme Cardiovascular, responsible for business development, alliance management and commercial planning for their cardiac gene therapy programs. Mr. Campbell has also worked in sales & marketing for Bristol-Myers Squibb and as a business strategy consultant for Marakon Associates.
Follow Bradley L Campbe:
About Amicus Therapeutics: Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Laurie Huard
Chief Operating Officer of Clinical Genomics Technologies
Follow Laurie Huard:
About Clinical Genomics Technologies: Clinical Genomics develops innovative products for colorectal cancer diagnosis.
Nayan Nanavati
Chief Operating Officer of BioClinica
Follow Nayan Nanavati:
About BioClinica: BioClinica provides integrated, technology-enhanced clinical trial management solutions.
Jing Wang
Co Founder & COO of iLabService
Follow Jing Wang:
About iLabService: ILabService simplifies lab operation by using IoT and AI technologies.
Alan Lyons
COO of SingletO2 Therapeutics
Alan Lyons currently works as the COO for SingletO2 Therapeutic.
Follow Alan Lyons:
About SingletO2 Therapeutics: SingletO2 Therapeutics develops new treatments for periodontal disease using singlet oxygen.